drugset / Trial / NCT06171607
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Phase 1
Recruiting
100 enrolled
University of Southern California
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Timeline
- Start
- 2020-11-05
- Primary completion
- 2026-11-05
- Completion
- 2027-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Definity | Diagnostic / imaging agent | — | Intravenous |
| Background | Lumason | Diagnostic / imaging agent | — | Intravenous |